D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 51 Citations 11,558 111 World Ranking 2578 National Ranking 117

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Antibody

Lubka T. Roumenina mainly focuses on Atypical hemolytic uremic syndrome, Immunology, Complement system, Alternative complement pathway and Factor H. In his study, Molecular biology, Endocrinology and C5-convertase is inextricably linked to Internal medicine, which falls within the broad field of Atypical hemolytic uremic syndrome. Lubka T. Roumenina specializes in Immunology, namely C3-convertase.

He works in the field of Complement system, namely CD46. His biological study spans a wide range of topics, including Classical complement pathway, Pathogenesis and Complement receptor. While the research belongs to areas of Factor H, Lubka T. Roumenina spends his time largely on the problem of Cell biology, intersecting his research to questions surrounding Neutrophil extracellular traps and Granulocyte.

His most cited work include:

  • Complement System Part I - Molecular Mechanisms of Activation and Regulation. (594 citations)
  • Complement System Part I - Molecular Mechanisms of Activation and Regulation. (594 citations)
  • Complement System Part I - Molecular Mechanisms of Activation and Regulation. (594 citations)

What are the main themes of his work throughout his whole career to date?

Lubka T. Roumenina focuses on Immunology, Complement system, Atypical hemolytic uremic syndrome, Alternative complement pathway and Complement factor B. Lubka T. Roumenina focuses mostly in the field of Immunology, narrowing it down to matters related to Glomerulopathy and, in some cases, Polyclonal antibodies. His Complement system research is multidisciplinary, incorporating elements of Hemolysis, Molecular biology and Complement.

The Atypical hemolytic uremic syndrome study combines topics in areas such as Endothelial stem cell, Glomerulonephritis, Internal medicine, Pathogenesis and Eculizumab. Lubka T. Roumenina usually deals with Alternative complement pathway and limits it to topics linked to Cell biology and Endothelium. His study focuses on the intersection of Complement factor B and fields such as Complement factor I with connections in the field of Pathology.

He most often published in these fields:

  • Immunology (91.07%)
  • Complement system (83.48%)
  • Atypical hemolytic uremic syndrome (64.29%)

What were the highlights of his more recent work (between 2017-2021)?

  • Complement system (83.48%)
  • Immunology (91.07%)
  • Hemolysis (9.37%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Complement system, Immunology, Hemolysis, Alternative complement pathway and Cell biology. His Complement system study focuses mostly on C3-convertase and Atypical hemolytic uremic syndrome. His study looks at the intersection of C3-convertase and topics like Autoantibody with Complement factor B and Lupus nephritis.

His work deals with themes such as Diagnostic marker and Glomerulopathy, which intersect with Immunology. The Alternative complement pathway study which covers Classical complement pathway that intersects with Cancer. His Cell biology research incorporates themes from RAGE and Glycation.

Between 2017 and 2021, his most popular works were:

  • Endothelium structure and function in kidney health and disease (84 citations)
  • Endothelium structure and function in kidney health and disease (84 citations)
  • Endothelium structure and function in kidney health and disease (84 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Antibody

Lubka T. Roumenina focuses on Complement system, Hemolysis, Endothelium, Inflammation and Hemopexin. A significant part of his Complement system research incorporates Immunology and Antibody studies. He studies C3-convertase which is a part of Immunology.

His Hemolysis study also includes

  • Red blood cell that intertwine with fields like Molecular biology,
  • Endothelial stem cell which connect with Hemoglobin, Haptoglobin, Nitric oxide and Cell biology,
  • Innate immune system which is related to area like Whole blood, CD59, Downregulation and upregulation and Endocrinology. Lubka T. Roumenina has included themes like Angiogenesis and Kidney, Renal fibrosis, Renal physiology in his Endothelium study. His Cancer research research integrates issues from Cancer, Atypical hemolytic uremic syndrome, Umbilical vein and Signalling.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Complement System Part I - Molecular Mechanisms of Activation and Regulation.

Nicolas S. Merle;Nicolas S. Merle;Nicolas S. Merle;Sarah Elizabeth Church;Sarah Elizabeth Church;Sarah Elizabeth Church;Veronique Fremeaux-Bacchi;Lubka T. Roumenina;Lubka T. Roumenina;Lubka T. Roumenina.
Frontiers in Immunology (2015)

798 Citations

Complement System Part II: Role in Immunity.

Nicolas S. Merle;Remi Noe;Lise Halbwachs-Mecarelli;Veronique Fremeaux-Bacchi.
Frontiers in Immunology (2015)

591 Citations

Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations

Fadi Fakhouri;Lubka Roumenina;François Provot;Marion Sallée.
Journal of The American Society of Nephrology (2010)

454 Citations

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

Aude Servais;Aude Servais;Laure-Hélène Noël;Lubka T. Roumenina;Moglie Le Quintrec.
Kidney International (2012)

449 Citations

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

Julien Zuber;Fadi Fakhouri;Lubka T. Roumenina;Chantal Loirat.
Nature Reviews Nephrology (2012)

426 Citations

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza.
Kidney International (2017)

352 Citations

Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort

Jane E. Salmon;Cara Heuser;Michael Triebwasser;M. Kathryn Liszewski.
PLOS Medicine (2011)

283 Citations

Complement factor H related proteins (CFHRs)

Christine Skerka;Qian Chen;Veronique Fremeaux-Bacchi;Lubka T. Roumenina;Lubka T. Roumenina;Lubka T. Roumenina.
Molecular Immunology (2013)

211 Citations

C1q and its growing family

Rohit Ghai;Patrick Waters;Lubka T. Roumenina;Mihaela Gadjeva.
Immunobiology (2007)

194 Citations

Complement alternative pathway acts as a positive feedback amplification of neutrophil activation.

Laurent Camous;Lubka Roumenina;Sylvain Bigot;Soumeya Brachemi.
Blood (2011)

187 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Lubka T. Roumenina

Véronique Frémeaux-Bacchi

Véronique Frémeaux-Bacchi

Inserm : Institut national de la santé et de la recherche médicale

Publications: 83

Peter F. Zipfel

Peter F. Zipfel

Leibniz Association

Publications: 55

Sébastien Lacroix-Desmazes

Sébastien Lacroix-Desmazes

Université Paris Cité

Publications: 55

Giuseppe Remuzzi

Giuseppe Remuzzi

Mario Negri Institute for Pharmacological Research

Publications: 46

David J. Kavanagh

David J. Kavanagh

Queensland University of Technology

Publications: 46

Santiago Rodríguez de Córdoba

Santiago Rodríguez de Córdoba

Spanish National Research Council

Publications: 45

John D. Lambris

John D. Lambris

University of Pennsylvania

Publications: 39

Richard J.H. Smith

Richard J.H. Smith

University of Iowa

Publications: 38

Alberto Mantovani

Alberto Mantovani

Humanitas University

Publications: 36

Marina Noris

Marina Noris

Mario Negri Institute for Pharmacological Research

Publications: 35

Zoltán Prohászka

Zoltán Prohászka

Semmelweis University

Publications: 30

Anna M. Blom

Anna M. Blom

Lund University

Publications: 29

Steffen Thiel

Steffen Thiel

Aarhus University

Publications: 28

Claire L. Harris

Claire L. Harris

Newcastle University

Publications: 26

Uday Kishore

Uday Kishore

Brunel University London

Publications: 26

Christine Skerka

Christine Skerka

Leibniz Association

Publications: 25

Trending Scientists

Lujo Bauer

Lujo Bauer

Carnegie Mellon University

Jun Liu

Jun Liu

Yangzhou University

Helmar Görls

Helmar Görls

Friedrich Schiller University Jena

Apparao M. Rao

Apparao M. Rao

Clemson University

Crisanto Gutierrez

Crisanto Gutierrez

Spanish National Research Council

Annick Harel-Bellan

Annick Harel-Bellan

Centre national de la recherche scientifique, CNRS

Gerald T. Keusch

Gerald T. Keusch

Boston University

Takehiro Hirose

Takehiro Hirose

Japan Agency for Marine-Earth Science and Technology

Kyoichi Otsuki

Kyoichi Otsuki

Kyushu University

Martin Vinck

Martin Vinck

Max Planck Society

Mark Mon-Williams

Mark Mon-Williams

University of Leeds

Rich S. W. Masters

Rich S. W. Masters

University of Waikato

James L. Riley

James L. Riley

University of Pennsylvania

Pamela L. Perrewé

Pamela L. Perrewé

Florida State University

Qazi Rahman

Qazi Rahman

King's College London

Michael J. Fine

Michael J. Fine

University of Pittsburgh

Something went wrong. Please try again later.